Quality-adjusted life years assessment using cabozantinib for patients with advanced hepatocellular carcinoma (aHCC) in the CELESTIAL trial.

被引：18
|
作者：
Abou-Alfa, Ghassan K.
Mollon, Patrick
Meyer, Tim
Cheng, Ann-Lii
El-Khoueiry, Anthony B.
Kelley, Robin Kate
Baron, Ari David
Benzaghou, Fawzi
Valcheva, Velichka Valerieva
Hazra, Saswati
Mangeshkar, Milan
Freemantle, Nicholas
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] IPSEN, Abingdon, Oxon, England
[3] UCL, Canc Inst, London, England
[4] Natl Taiwan Univ Hosp, Taipei, Taiwan
[5] Natl Taiwan Univ, Canc Ctr, Taipei, Taiwan
[6] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA
[7] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
[8] Pacific Hem Onc Assoc, Mill Valley, CA USA
[9] IPSEN, Paris, France
[10] Ipsen Pharma SAS, Paris, France
[11] Prometheus Lab Inc, San Diego, CA USA
[12] Exelixis Inc, San Francisco, CA USA
[13] UCL, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.207
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
207
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial
    Kelley, Robin Kate
    Ryoo, Baek-Yeol
    Merle, Philippe
    Park, Joong-Won
    Bolondi, Luigi
    Chan, Stephen L.
    Lim, Ho Yeong
    Baron, Ari D.
    Parnis, Francis
    Knox, Jennifer
    Cattan, Stephane
    Yau, Thomas
    Lougheed, Julie C.
    Milwee, Steven
    El-Khoueiry, Anthony B.
    Cheng, Ann-Lii
    Meyer, Tim
    Abou-Alfa, Ghassan K.
    ESMO OPEN, 2020, 5 (04) : 1 - 9
  • [42] Outcomes based on albumin-bilirubin (ALBI) grade in the phase III CELESTIAL trial of cabozantinib versus placebo in patients with advanced hepatocellular carcinoma (HCC)
    Chan, S. L.
    Miksad, R.
    Cicin, I.
    Chen, Y.
    Klumpen, H. J.
    Kim, S.
    Lin, Z. Z.
    Youkstetter, J.
    Sen, S.
    Cheng, A-L.
    El-Khoueiry, A. B.
    Meyer, T.
    Kelley, R. K.
    Abou-Alfa, G. K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [43] Integrating Mortality and Morbidity Outcomes Using Quality-adjusted Life Years in Critical Care Trials
    Ferguson, Niall D.
    Scales, Damon C.
    Pinto, Ruxandra
    Wilcox, M. Elizabeth
    Cook, Deborah J.
    Guyatt, Gordon H.
    Schuenemann, Holger J.
    Marshall, John C.
    Herridge, Margaret S.
    Meade, Maureen O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187 (03) : 256 - 261
  • [44] Assessment of Economic Value of Assistive Technologies Through Quality-Adjusted Work-Life Years (QAWLY)
    Joseph, Siny
    Namboodiri, Vinod
    COMPUTERS HELPING PEOPLE WITH SPECIAL NEEDS, ICCHP 2020, PT II, 2020, 12377 : 480 - 488
  • [45] Cost-effectiveness of losartan in patients with hypertension and left ventricular hypertrophy: cost per quality-adjusted life years gained in the LIFE trial
    Jonsson, B
    Carides, GW
    Burke, TA
    Dasbach, EJ
    Lindholm, LH
    Dahlof, B
    EUROPEAN HEART JOURNAL, 2004, 25 : 331 - 331
  • [46] Quality-adjusted life years gained in patients aged over 65 years after total hip replacement
    Hordam, B.
    Pedersen, P. U.
    Soballe, K.
    Sabroe, Svend
    Ehlers, L. H.
    INTERNATIONAL JOURNAL OF ORTHOPAEDIC AND TRAUMA NURSING, 2011, 15 (01) : 11 - 17
  • [47] Quality-Adjusted Life Years and Disability-Adjusted Life Years Are Better With Concurrent Chemoradiation Therapy Than Induction Chemotherapy Followed by Chemoradiation Therapy in Nasopharyngeal Carcinoma
    Nittala, Mary R.
    Kanakamedala, Madhava R.
    Mundra, Eswar
    Woods, William C., III
    Smith, Maria L.
    Hamilton, Robert D.
    Jefferson, Gina D.
    Jackson, Lana
    Packianathan, Satya
    Vijayakumar, Srinivasan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (01)
  • [48] Total Hip Arthroplasty Improves the Quality-Adjusted Life Years in Patients Who Exceeded the Estimated Life Expectancy
    Dimitriou, Dimitris
    Antoniadis, Alexander
    Flury, Andreas
    Liebhauser, Martin
    Helmy, Naeder
    JOURNAL OF ARTHROPLASTY, 2018, 33 (11): : 3484 - 3489
  • [49] Total knee arthroplasty improves the quality-adjusted life years in patients who exceeded their estimated life expectancy
    Michele Palazzuolo
    Alexander Antoniadis
    Jaad Mahlouly
    Julien Wegrzyn
    International Orthopaedics, 2021, 45 : 635 - 641
  • [50] Total knee arthroplasty improves the quality-adjusted life years in patients who exceeded their estimated life expectancy
    Palazzuolo, Michele
    Antoniadis, Alexander
    Mahlouly, Jaad
    Wegrzyn, Julien
    INTERNATIONAL ORTHOPAEDICS, 2021, 45 (03) : 635 - 641
12345